Pro-Dex (Pro-Dex) GF Value

: $20.84 (As of Today)

View and export this data going back to 1986. Start your Free Trial

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-18), Pro-Dex's share price is $18.75. Pro-Dex's GF Value is $20.84. Therefore, Pro-Dex's Price-to-GF-Value for today is 0.90.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Pro-Dex is Modestly Undervalued.

Pro-Dex (NAS:PDEX) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Pro-Dex's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	18.75	/	20.84
	=	0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex GF Value Related Terms

Thank you for viewing the detailed overview of Pro-Dex's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro-Dex (Pro-Dex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

PDXN:Germany

Address

2361 McGaw Avenue, Irvine, CA, USA, 92614

Website

https://www.pro-dex.com

Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Executives

Angelita Rebamontan Domingo	director	1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr	director, officer: Chief Executive Officer	34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer	director	5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii	director	20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg	10 percent owner	12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton	officer: Chief Financial Officer	25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson	10 percent owner	5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot	director	3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda	director
Farnam Street Partners Lp /mn	10 percent owner	3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp	10 percent owner	5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder	director	1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey	director	101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot	director	P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac	director	36 WHISPER DRIVE, WORCESTER MA 01609